Merck v. Integra: Bailing Water Without Plugging the Hole.
- Published in:
- BYU Journal of Public Law, 2006, v. 20, n. 2, p. 579
- By:
- Publication type:
- Article
Works matching Merck
Results: 5000
1
2
Flexibility implementation to a global workforce: a case study of Merck and Company, Inc.
- Published in:
- Community, Work & Family, 2011, v. 14, n. 2, p. 249, doi. 10.1080/13668803.2011.571404
- By:
- Publication type:
- Article
3
The Patent Research Tool Problem After Merck v. Integra.
- Published in:
- Texas Intellectual Property Law Journal, 2005, v. 14, n. 1, p. 1
- By:
- Publication type:
- Article
4
Deviations and Conversions, Seventies Style: Mandy Merck in Conversation with Laura Guy.
- Published in:
- Third Text, 2021, v. 35, n. 1, p. 11, doi. 10.1080/09528822.2020.1864975
- By:
- Publication type:
- Article
5
INTEGRA LIFESCIENCES I, LTD. V. MERCK KGAA: RE-EXAMINING THE BROAD SCOPE OF THE § 271(E)(1) SAFE HARBOR.
- Published in:
- Berkeley Technology Law Journal, 2008, v. 23, n. 1, p. 107
- By:
- Publication type:
- Article
6
Boston University School of Law Merck KGaA v. Integra Lifesciences I, Ltd: Implications of the Supreme Court's Decision for the People Who Matter Most… the Consumer.
- Published in:
- American Journal of Law & Medicine, 2007, v. 33, n. 1, p. 97, doi. 10.1177/009885880703300103
- By:
- Publication type:
- Article
7
Eine „Schandgasse" im Arbeitskampf: Der Chemiestreik 1971 bei Merck in Darmstadt – eine Fallstudie zu den industriel-len Beziehungen in der Bundesrepublik am Ende des „Wirtschaftswunders".
- Published in:
- Vierteljahrshefte für Zeitgeschichte, 2020, v. 68, n. 3, p. 409, doi. 10.1515/vfzg-2020-0026
- By:
- Publication type:
- Article
8
Revivals of an Ancient Myth in Modern Art: Oedipus and the Episode of the Sphinx. From Jean Auguste-Domenique Ingres to Michael Merck.
- Published in:
- Trends in Classics, 2011, v. 3, n. 1, p. 154, doi. 10.1515/tcs.2011.008
- By:
- Publication type:
- Article
9
Reconstructing Merck's Practical Theory of Communication: The Ethics of Pharmaceutical Sales Representative-Physician Encounters.
- Published in:
- Communication Monographs, 2011, v. 78, n. 1, p. 53, doi. 10.1080/03637751.2010.542578
- By:
- Publication type:
- Article
10
An Early Collection of the Red Alga Mikamiella ruprechtiana Made by Carl Merck on the Billing Expedition to Alaska (1785-94).
- Published in:
- Arctic Journal, 2006, v. 59, n. 4, p. 365
- By:
- Publication type:
- Article
11
"Putting Patients First": Systematically Distorted Communication and Merck's Marketing of Vioxx.
- Published in:
- Journal of Applied Communication Research, 2007, v. 35, n. 4, p. 376, doi. 10.1080/00909880701611052
- By:
- Publication type:
- Article
12
Merck and Vioxx: An Examination of an Ethical Decision-Making Model.
- Published in:
- Journal of Business Ethics, 2007, v. 76, n. 4, p. 451, doi. 10.1007/s10551-006-9302-3
- By:
- Publication type:
- Article
13
Revitalizing portfolio decision-making at Merck Serono S.A. - Geneva.
- Published in:
- Journal of Commercial Biotechnology, 2011, v. 17, n. 1, p. 24, doi. 10.1057/jcb.2010.26
- By:
- Publication type:
- Article
14
Preserving biodiversity in Costa Rica: the case of the Merck-INBio Agreement
- Published in:
- Journal of Environment & Development, 1997, v. 6, n. 2, p. 180, doi. 10.1177/107049659700600206
- By:
- Publication type:
- Article
15
Open conflict on the handling of the Merck drug Vioxx by editorial giants.
- Published in:
- Reproductive BioMedicine Online (Reproductive Healthcare Limited), 2006, v. 13, n. 6, p. 905, doi. 10.1016/S1472-6483(10)61040-1
- By:
- Publication type:
- Article
16
األدلح الشة اللغوية في كتاب شرمائل المحمديازية لميرك شاه الشير (ت بعد930هـ).
- Published in:
- Journal of Anbar University for Languages & Literature / Magallat Gami'at Al-Anbar Li-Lugat Wa-al-Adabl, 2022, n. 36, p. 351
- By:
- Publication type:
- Article
17
Bilanz Merck 2022: Medikamente und Halbleiterprodukte.
- Published in:
- Nachrichten aus der Chemie, 2023, v. 71, n. 4, p. 46, doi. 10.1002/nadc.20234135236
- By:
- Publication type:
- Article
18
Merck: Forschung, Pharma und Halbleiter.
- Published in:
- Nachrichten aus der Chemie, 2022, v. 70, n. 5, p. 50, doi. 10.1002/nadc.20224124097
- Publication type:
- Article
19
Merck Helps/Merck Access Program.
- Published in:
- Oncology Practice Management, 2019, p. 80
- Publication type:
- Article
20
Das wissenschaftliche Unternehmen: Zur chemisch-pharmazeutischen Forschung bei E. Merck, Darmstadt, ca. 1900 bis 1930.
- Published in:
- Zeitschrift für Unternehmensgeschichte, 2017, v. 62, n. 2, p. 163, doi. 10.1515/zug-2017-1003
- By:
- Publication type:
- Article
21
The evolution of drug design at Merck Research Laboratories.
- Published in:
- Journal of Computer-Aided Molecular Design, 2017, v. 31, n. 3, p. 255, doi. 10.1007/s10822-016-9993-1
- By:
- Publication type:
- Article
22
Merck's 21-Valent Pneumococcal Vaccine Delivers More Positive Phase 3 Data in Advance of 6-17-2024 PDUFA Date.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
23
Merck's Actions Surrounding Vioxx.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
24
Merck Helps/Merck Access Program.
- Published in:
- Oncology Practice Management, 2023, p. 82
- Publication type:
- Article
25
Merck Helps/Merck Access Program.
- Published in:
- 2020
- Publication type:
- Product Review
26
Merck Helps/Merck Access Program.
- Published in:
- 2018
- Publication type:
- Product Review
27
Pharmaceutical Research in Wilhelmine Germany: The Case of E. Merck.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
28
Screening antibiotics: industrial research by CEPA and Merck in the 1950s.
- Published in:
- Dynamis, 2011, v. 31, n. 2, p. 407, doi. 10.4321/S0211-95362011000200008
- By:
- Publication type:
- Article
29
APOTEX USA, INC. V. MERCK & CO., INC.
- Published in:
- Berkeley Technology Law Journal, 2002, v. 17, n. 1, p. 144
- Publication type:
- Article
30
Bilanz 2020: Merck.
- Published in:
- Nachrichten aus der Chemie, 2021, v. 69, n. 5, p. 55, doi. 10.1002/nadc.20214106999
- By:
- Publication type:
- Article
31
Bilanz Merck: für Forscher und Flüssigkristalle.
- Published in:
- Nachrichten aus der Chemie, 2017, v. 65, n. 4, p. 447, doi. 10.1002/nadc.20174061436
- By:
- Publication type:
- Article
32
Merck Drug Prevents Serious Infection After Marrow Transplant: Study.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 11, p. i, doi. 10.1093/cid/cix261
- By:
- Publication type:
- Article
33
Serono sold to Merck.
- Published in:
- Reproductive BioMedicine Online (Reproductive Healthcare Limited), 2006, v. 13, n. 5, p. 650
- Publication type:
- Article
34
Realizing the potential of a multinational, multicultural organization: Lessons learned at Merck Serono.
- Published in:
- Global Business & Organizational Excellence, 2010, v. 30, n. 1, p. 7, doi. 10.1002/joe.20354
- By:
- Publication type:
- Article
35
The Aftermath of Merck: D&O Insecurity in the Security Fraud Arena.
- Published in:
- Pace Law Review, 2012, v. 32, n. 1, p. 217, doi. 10.58948/2331-3528.1798
- By:
- Publication type:
- Article
36
"Not Just for Doctors Anymore": How the Merck Manual Became a Consumer Health "Bible".
- Published in:
- Bulletin of the History of Medicine, 2021, v. 95, n. 1, p. N.PAG, doi. 10.1353/bhm.2021.0000
- By:
- Publication type:
- Article
37
The German Connection: Merck and the Flow of Knowledge from Germany to the United States, 1880- 1930.
- Published in:
- Business & Economic History On-Line, 2011, v. 9, p. 1
- By:
- Publication type:
- Article
38
Merck Hopes To Extend Gardasil Vaccine to Men.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 4, p. 222, doi. 10.1093/jnci/djp014
- By:
- Publication type:
- Article
39
Merck tests needle-free vaccines.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 12, p. 1155, doi. 10.1038/nbt1212-1155a
- By:
- Publication type:
- Article
40
Swiss hope for phoenix from Merck Serono's ashes.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 569, doi. 10.1038/nbt0712-569
- By:
- Publication type:
- Article
41
Merck joins the biotech game.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 2, p. 104, doi. 10.1038/nbt0209-104
- By:
- Publication type:
- Article
42
Merck splashes on Cubist, antibiotics prospects brighten.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 2, p. 120, doi. 10.1038/nbt0215-120
- By:
- Publication type:
- Article
43
Merck KgaA v. Integra Life Sciences: US Supreme Court clarifies scope of the safe harbor provision.
- Published in:
- Journal of Generic Medicines, 2005, v. 3, n. 1, p. 75, doi. 10.1057/palgrave.jgm.4940101
- Publication type:
- Article
44
Merck Manuals Information Online <http://www.merck.com/mmhe>.
- Published in:
- Journal of Consumer Health on the Internet, 2009, v. 13, n. 1, p. 66, doi. 10.1080/15398280802674883
- By:
- Publication type:
- Article
45
Merck blocks `safer' gene therapy trials.
- Published in:
- Nature, 2000, v. 403, n. 6772, p. 817, doi. 10.1038/35002743
- By:
- Publication type:
- Article
46
Warum Merck und Merck nicht dasselbe sind.
- Published in:
- Chemie in unserer Zeit, 2018, v. 52, n. 6, p. 378, doi. 10.1002/ciuz.201800870
- By:
- Publication type:
- Article
47
Merck fellowships contribute to the continued growth of clinical pharmacology in Sweden.
- Published in:
- 2007
- By:
- Publication type:
- Letter
48
UPDATE: ACIP Vote Unanimous to Recommend Merck 21-Valent Pneumococcal Shot for Older Adults.
- Published in:
- Patient Care (Online), 2024, p. 35
- By:
- Publication type:
- Article
49
Merck's 21-Valent Adult-Specific Pneumococcal Vaccine Accrues New Phase 3 and Real World Data.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
50
Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil.
- Published in:
- Journal of Law, Medicine & Ethics, 2012, v. 40, n. 3, p. 673, doi. 10.1111/j.1748-720X.2012.00698.x
- By:
- Publication type:
- Article